Global Advanced Parenteral Drug Delivery Devices Market Size By Type (Prefillable Syringes, IV Catheters), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Advanced Parenteral Drug Delivery Devices Market was valued at USD 18.6 billion in 2023 and is expected to surpass USD 34.1 billion by 2031, growing at a CAGR of 7.9% during the forecast period of 2023–2031. This growth is primarily fueled by the increasing prevalence of chronic diseases, rising demand for biologics and biosimilars, and the growing need for patient-friendly, self-administrable drug delivery solutions. Advanced parenteral drug delivery systems—such as auto-injectors, prefilled syringes, and infusion pumps—offer improved therapeutic efficacy, patient compliance, and minimized risk of dosing errors, making them vital components of modern healthcare infrastructure.

Drivers

1. Rising Prevalence of Chronic Diseases

An aging global population and the growing incidence of diseases such as diabetes, cancer, and autoimmune disorders are boosting the need for effective parenteral drug delivery methods that offer precision, speed, and reduced discomfort.

2. Growing Demand for Biologics and Biosimilars

Biologics often require parenteral administration. As the pharmaceutical industry shifts towards these large-molecule therapies, there is increased adoption of advanced drug delivery systems capable of managing viscosity and sensitive formulation handling.

3. Increased Adoption of Self-Administered Devices

The growing trend of home healthcare and patient self-management is driving demand for user-friendly devices like wearable injectors and auto-injectors, which support regular therapy without the need for clinical visits.

Restraints

1. High Cost of Development and Devices

The complex design, stringent regulatory requirements, and use of high-end materials contribute to elevated costs, which can hinder adoption in low-resource settings and smaller healthcare facilities.

2. Risk of Contamination and Safety Concerns

Despite technological advances, concerns about sterility, device malfunctions, and needle-stick injuries still pose significant barriers, especially in regions with limited healthcare oversight.

Opportunity

1. Technological Innovations in Delivery Systems

Smart injectors, connected drug delivery platforms, and digital health integration present new opportunities to enhance therapy monitoring, adherence, and personalization in patient treatment.

2. Expansion in Emerging Markets

Improving healthcare infrastructure and rising investments in biotechnology sectors in Asia-Pacific, Latin America, and the Middle East offer significant opportunities for market penetration and growth.

Market by System Type Insights

Based on system type, the Prefilled Syringes segment accounted for the largest revenue share in 2023. Prefilled syringes offer reduced drug waste, improved dosing accuracy, and enhanced patient safety. The Auto-injectors segment is projected to grow at the fastest rate, driven by the rising adoption of biologics, ease of use, and expanding applications in emergency and chronic disease settings.

Market by End-use Insights

In terms of end use, the Hospitals & Clinics segment held the largest market share in 2023. This is due to the wide-scale use of parenteral devices for inpatient and outpatient therapeutic procedures. Meanwhile, the Homecare Settings segment is witnessing robust growth, attributed to the surge in chronic disease cases and the rising preference for self-administration and remote patient monitoring.

Market by Regional Insights

Geographically, North America dominated the Global Advanced Parenteral Drug Delivery Devices Market in 2023, driven by strong healthcare infrastructure, rapid uptake of novel therapies, and the presence of major market players. Asia-Pacific is anticipated to register the highest CAGR during the forecast period, propelled by increasing healthcare spending, large patient pools, and growing acceptance of innovative drug delivery technologies.

Competitive Scenario

Key players in this market include Becton, Dickinson and Company, Gerresheimer AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, SCHOTT AG, Terumo Corporation, Baxter International Inc., and SHL Medical. These companies are focusing on strategic collaborations, technological advancements, and geographical expansion to enhance their competitive positioning.

Key Market Developments:

In 2023, BD launched a next-generation wearable injector for subcutaneous biologic drug delivery.

In 2024, West Pharma partnered with a leading biotech firm to co-develop smart auto-injectors integrated with adherence tracking sensors.

In 2025, Ypsomed announced the expansion of its production facility in Germany to meet growing demand for self-injection systems.

Scope of Work – Global Advanced Parenteral Drug Delivery Devices Market

Report Metric Details

Market Size (2023) USD 18.6 billion

Projected Market Size (2031) USD 34.1 billion

CAGR (2023–2031) 7.9%

Market Segments By System Type (Prefilled Syringes, Auto-injectors, Infusion Pumps), By End-Use (Hospitals & Clinics, Homecare Settings)

Growth Drivers Rise in chronic disease prevalence, biologics demand, homecare trends

Opportunities Smart delivery systems, emerging market expansion

FAQs

1) What is the current market size of the G